←
Matthew Pillar603 posts
Matthew Pillar avatar

Matthew Pillar

@mattpillar

I like it better on LinkedIn -- follow me there! linkedin.com/in/matthewpilla…

◷ Joined June 2010▧ 109 Photos and videos
Matthew Pillar avatar
Matthew Pillar@mattpillar·3 May 2021

On this fresh episode of the #businessofbiotech podcast, learn how @organicellTM CSO @MariMitrani and Lab Director Dr. Michael Bellio leverage #bioinformatics to discover the therapeutic potential of perinatal tissue-secreted #exosomes. bioprocessonline.com/doc/dig…

Matthew Pillar avatar
Matthew Pillar@mattpillar·30 Apr 2021

Ease into the weekend with the latest episode of #businessofbiotech featuring regulatory environment musings with bluebird bio's @scleve14, then tune in Monday for insight from Organicell Regenerative Medicine's @MariMitrani and D…lnkd.in/evEiMAg lnkd.in/eWU_VNQ

Matthew Pillar avatar
Matthew Pillar@mattpillar·27 Apr 2021

How close are we to manufacturing autologous cell therapies in hospital cleanrooms? Clinical-stage #celltherapy company @Precigen and its CEO Dr. Helen Sabzevari say closer than you might think. #businessofbiotech via @BioProcessOL bioprocessonline.com/doc/dec…

Matthew Pillar avatar
Matthew Pillar@mattpillar·19 Apr 2021

Nearly 85% of 18-to-65 year-olds will have at least one strain of #HPV at some point in their life. The #hpvvaccine prevents a host of #cancers, but for whole generations, it came too late. Cue Biopharma CEO Daniel Passeri shares w…lnkd.in/d_Z6yC9 lnkd.in/da4b2nk

Matthew Pillar avatar
Matthew Pillar@mattpillar·8 Apr 2021

"Most people who must climb a ladder do not manage the severity of falling off a ladder. They manage the risk event by taking steps to decrease the likelihood of a fall," says Mark F. Witcher, Ph.D. as he argues to replace RPN with…lnkd.in/ezA_dUn lnkd.in/eUfFFQw

Matthew Pillar avatar
Matthew Pillar@mattpillar·5 Apr 2021

This week on The Business of Biotech, Rezolute, Inc. CEO Nevan Charles Elam shares the company's rationale for pursuing congenital #hyperinsulinism and #diabetic macular edema therapeutics by leveraging monoclonal antibodies and di…lnkd.in/eQy74Ce lnkd.in/emcXz6T

Matthew Pillar avatar
Matthew Pillar@mattpillar·26 Mar 2021

With backing from heavyweights like Dr. Peter H. Diamandis and @tonyrobbins, Elevian, Inc. CEO Dr. Mark Allen seeks to release the power of a naturally-occurring molecule known as growth differentiation factor 11 to combat age-rela…lnkd.in/etiNew9 lnkd.in/eCdXsqF